Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

NARecruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Melasma

Interventions

OTHER

Group TP

Application full face, twice daily, in the morning and at bedtime for 4 months

DRUG

Group CYS

Application short contact, of thin layer once daily at bedtime for 4 months

Trial Locations (1)

RECRUITING

MS Clinical Research Pvt. Ltd, Bangalore